Association of acetylcholine receptor α-subunit gene expression in mixed thymoma with myasthenia gravis

Neurology

Volumn 52, Issue 7, 1999, Pages 1460-1466

  Wilisch, A ^c   Gutsche, S ^c   Hoffacker, V ^c   Schultz, A ^c   Tzartos, S ^a   Nix, W ^c   Schalke, B ^c   Schneider, C ^c   Muller Hermelink H K ^c   Marx, Alexander ^b  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CHOLINERGIC RECEPTOR;

ALPHA CHAIN; ALTERNATIVE RNA SPLICING; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNITY; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; MOLECULAR MIMICRY; MYASTHENIA GRAVIS; PRIORITY JOURNAL; RECEPTOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYMOMA;

EID: 0033594529     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.7.1460     Document Type: Article

References (40)

1. Lindstrom J, Shelton D, Fujii Y. Myasthenia gravis. Adv Immunol 1988;42:233-284.
2. Tzartos SJ, Barkas T, Cung MT, et al. Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor. Immunol Rev 1998;163: 89-120.
3. Vincent A. Aetiological factors in development of myasthenia gravis. Adv Neuroimmunol 1994;4:355-371.
4. Sumikawa K, Miledi R. Assembly and insertion of a multisubunit nicotinic acetylcholine receptor into plasma membranes. In: Maelicke A, ed. Molecular biology of neuroreceptors and ion channels. Berlin: Springer-Verlag, 1989: 451-467.
5. Tzartos SJ, Seybold ME, Lindstrom J. Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies. Proc Natl Acad Sci USA 1982;79:188-192.
6. Beeson D, Morris A, Vincent A, Newsom Davis J. The human muscle nicotinic acetylcholine receptor alpha-subunit exist as two isoforms: a novel exon. EMBO J 1990;9:2101-2106.
7. Newland CF, Beeson D, Vincent A, Newsom-Davis J. Functional and non-functional isoforms of the human muscle acetylcholine receptor. J Physiol (Lond) 1995;489:767-778.
8. Lindstrom J. Neuronal nicotinic acetylcholine receptors. In: Narahashi T, ed. Ion channels. New York: Plenum Press, 1996:377-450.
9. Mihovilovic M, Roses AD. Expression of alpha-3, alpha-5, and beta-4 neuronal acetylcholine receptor subunit transcripts in normal and myasthenia gravis thymus: identification of thymocytes expressing the alpha-3 transcripts. J Immunol 1993; 151:6517-6524.
10. Willcox N. Myasthenia gravis. Curr Opin Immunol 1993;5: 910-917.
11. Sommer N, Harcourt GC, Willcox N, Beeson D, Newsom-Davis J. Acetylcholine receptor-reactive T lymphocytes from healthy subjects and myasthenia gravis patients. Neurology 1991;41:1270-1276.
12. Meinl E, Klinkert WE, Wekerle H. The thymus in myasthenia gravis: changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat. Am J Pathol 1991;139:995-1008.
13. Schluep M, Willcox N, Vincent A, Dhoot GK, Newsom-Davis J. Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study. Ann Neurol 1987;22:212-222.
14. Wekerle H, Ketelsen UP. Intrathymic pathogenesis and dual genetic control of myasthenia gravis. Lancet 1977;1:678-680.
15. Müller-Hermelink HK, Wilisch A, Schultz A, Marx A. Characterization of the human thymic microenvironment: lymphoepithelial interaction in normal thymus and thymoma. Arch Histol Cytol 1997;60:9-28.
16. Nenninger R, Schultz A, Hoffacker V, et al. Abnormal thymocyte development and generation of autoreactive T cells in mixed and cortical thymomas. Lab Invest 1998;78:743-753.
17. Kirchner T, Schalke B, Buchwald J, Ritter M, Marx A, Müller-Hermelink HK. Well-differentiated thymic carcinoma: an organotypical low-grade carcinoma with relationship to cortical thymoma. Am J Surg Pathol 1992;16:1153-1169.
18. Kornstein MJ, Asher O, Fuchs S. Acetylcholine receptor alpha-subunit and myogenin mRNAs in thymus and thymomas. Am J Pathol 1995;146:1320-1324.
19. Kirchner T, Tzartos S, Hoppe F, Schalke B, Wekerle H, Muller-Hermelink HK. Pathogenesis of myasthenia gravis: acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors. Am J Pathol 1988;130:268-280.
20. Marx A, O'Connor R, Geuder KI, et al. Characterization of a protein with an acetylcholine receptor epitope from myasthenia gravis-associated thymomas. Lab Invest 1990;62:279-286.
21. Müller-Hermelink HK, Marx A, Kirchner T. Advances in the diagnosis and classification of thymic epithelial tumors. In: Anthony P, MacSween R, eds. Recent advances in histopathology. Edinburgh: Churchill Livingstone, 1994:49-63.
22. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981;48:2485-2492.
23. Kirchner T, Schalke B, Melms A, von Kugelgen T, Müller-Hermelink HK. Immunohistological patterns of nonneoplastic changes in the thymus in myasthenia gravis. Virchows Arch [B] 1986;52:237-257.
24. Loutrari H, Kokla A. Trakas N, Tzartos SJ. Expression of human-torpedo hybrid acetylcholine receptor (AChR) for analysing the subunit specificity of antibodies in sera from patients with myasthenia gravis (MG). Clin Exp Immunol 1997; 109:538-546.
25. Tzartos SJ, Kouvatsou R, Tzartos E. Monoclonal antibodies as site-specific probes for the acetylcholine-receptor delta-subunit tyrosine and serine phosphorylation sites. Eur J Biochem 1995;228:463-472.
26. Tzartos SJ, Remoundos MS. Precise epitope mapping of monoclonal antibodies to the cytoplasmic side of the acetylcholine receptor alpha subunit: dissecting a potentially myasthenogenic epitope. Eur J Biochem 1992;207:915-922.
27. Talib S, Okarma TB, Lebkowski JS. Differential expression of human nicotinic acetylcholine receptor alpha subunit variants in muscle and non-muscle tissues. Nucleic Acids Res 1993;21: 233-237.
28. Andreetta F, Baggi F, Antozzi C, et al. Acetylcholine receptor alpha-subunit isoforms are differentially expressed in thymuses from myasthenic patients. Am J Pathol 1997;150:341-348.
29. Guyon T, Levasseur P, Truffault F, et al. Regulation of acetylcholine receptor alpha subunit variants in human myasthenia gravis: quantification of steady-state levels of messenger RNA in muscle biopsy using the polymerase chain reaction. J Clin Invest 1994;94:16-24.
30. Sine SM, Claudio T. Gamma-and delta-subunits regulate the affinity and the cooperativity of ligand binding to the acetylcholine receptor. J Biol Chem 1991;266:19369-19377.
31. Simon AM, Burden SJ. An E box mediates activation and repression of the acetylcholine receptor delta-subunit gene during myogenesis. Mol Cell Biol 1993;13:5133-5140.
32. Wilisch A, Schultz A, Jung A, et al. Titin epitope in thymoma. In: Marx A, Müller-Hermelink HK, eds. Epithelial tumors of the thymus. New York: Plenum Press, 1997:221-227.
33. Kirchner T, Hoppe F, Schalke B, Müller-Hermelink HK. Microenvironment of thymic myoid cells in myasthenia gravis. Virchows Arch [B] 1988;54:295-302.
34. Hämmerling G, Schonrich G, Momburg F, et al. Non-deletional mechanisms of peripheral and central tolerance: studies with transgenic mice with tissue-specific expression of a foreign MHC class I antigen. Immunol Rev 1991;122:47-67.
35. Naujokas MF, Arneson LS, Fineschi B, et al. Potent effects of low levels of MHC class II-associated invariant chain on CD4+ T cell development. Immunity 1995;3:359-372.
36. Pugliese A, Zeller M, Fernandez A Jr, et al. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 1997;15: 293-297.
37. Vafiadis P, Bennett ST, Todd JA, et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet 1997;15:289-292.
38. Salmon AM, Bruand C, Cardona A, Changeux JP, Berrih-Aknin S. An acetylcholine receptor alpha subunit promoter confers intrathymic expression in transgenic mice: implications for tolerance of a transgenic self-antigen and for autoreactivity in myasthenia gravis [in process citation]. J Clin Invest 1998;101:2340-2350.
39. Sommer N, Willcox N, Harcourt GC, Newsom Davis J. Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor-reactive T cells. Ann Neurol 1990;28: 312-319.
40. Marx A, Wilisch A, Schultz A, Gattenlöhner S, Nenninger R, Müller-Hermelink HK. Pathogenesis of myasthenia gravis. Virchows Arch 1997;430:355-364.